Literature DB >> 7093296

Effects of 12-O-tetradecanoylphorbol 13-acetate on glycerolipid metabolism in cultured myoblasts.

R I Grove, S D Schimmel.   

Abstract

We recently reported that treatment of differentiated chick embryo myoblasts in culture with the potent tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) caused a 2-fold increase in the level of 1,2-diacylglycerol in the plasma membrane fraction within 15-30 min (Grove, R.I. and Schimmel, S.D. (1981) Biochem. Biophys. Res. Commun. 102, 158-164). This system has been characterized further and the metabolic origin and fate of the stimulated diacylglycerol have been investigated. The stimulation of 1,2-diacylglycerol was insensitive to alterations of Ca2+ concentration in the medium and to the presence of inhibitors of Ca2+ flux, protein synthesis and prostaglandin synthesis. The fatty acid composition of the newly formed diacylglycerol was similar to that of phosphatidylcholine. In addition, the glycerol moiety of the diacylglycerol was shown to be derived from a lipid with metabolic turnover similar to that of phosphatidylcholine. The tumor promoter was also found to stimulate rapidly synthesis of phosphatidic acid, phosphatidylinositol and phosphatidylcholine. A possible model is proposed, therefore, in which the tumor promoter stimulates a membrane-associated phospholipase C which generates 1,2-diacylglycerol via the hydrolysis of phosphatidylcholine. The newly formed diacylglycerol is then metabolized back to phosphatidylcholine or to phosphatidic acid and phosphatidylinositol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093296     DOI: 10.1016/0005-2760(82)90036-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

2.  A tumour promoter, 12-O-tetradecanoylphorbol 13-acetate, increases cellular 1,2-diacylglycerol content through a mechanism other than phosphoinositide hydrolysis in Swiss-mouse 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa; H Rasmussen
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

3.  Stimulation of phospholipid hydrolysis and arachidonic acid mobilization in human uterine decidua cells by phorbol ester.

Authors:  M P Schrey; A M Read; P J Steer
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

Review 4.  The fusion of myoblasts.

Authors:  M J Wakelam
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

5.  Evidence from studies employing radioactively labelled fatty acids that the stimulation of flux through the diacylglycerol pool is an early action of vasopressin on hepatocytes.

Authors:  L B Pickford; A J Polverino; G J Barritt
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

6.  Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II).

Authors:  K Nishio; Y Sugimoto; Y Fujiwara; T Ohmori; T Morikage; Y Takeda; M Ohata; N Saijo
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Ascorbic acid facilitates chicken myoblast fusion in vitro.

Authors:  R G MacBride
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

8.  Oncostatin M is a mitogen for rabbit vascular smooth muscle cells.

Authors:  R I Grove; C Eberhardt; S Abid; C Mazzucco; J Liu; P Kiener; G Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

9.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

10.  Stimulation of phosphatidylcholine synthesis by activators of protein kinase C is dissociable from increased phospholipid hydrolysis.

Authors:  Z Kiss; J Chattopadhyay; G R Pettit
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.